Cross-sectional Study to Investigate the Effects of Chronic Obstructive Pulmonary Disease on Daily Life Activities

Overview

The purpose of this study is to investigate the effects of Chronic Obstructive Pulmonary Disease (COPD) on daily life activities in patients with COPD and also to determine the socio-demographic profile, daily life style and needs of the patients with COPD.

Full Title of Study: “Cross-sectional Observational Study to Investigate the Effects of Chronic Obstructive Pulmonary Disease on Daily Life Activities”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: June 2011

Arms, Groups and Cohorts

  • Patients with COPD

Clinical Trial Outcome Measures

Primary Measures

  • Effect of COPD on daily activities
    • Time Frame: 1 year
    • The distribution of the patients according to their answers, as Yes / No / Unknown, given to the questions of patient questionnaire about the effect of COPD on daily life and which daily activities are limited will be calculated as percentage.

Secondary Measures

  • Patients’ socio-demographic profiles, daily life conditions and needs and expectations from therapy
    • Time Frame: Baseline
    • The answers the patients give to the questions about socio-demographic profiles, daily life conditions and needs and their expectations from the therapy will be summarized as percentages: Age and gender, educational background, place of residence, marital status and life conditions, concomitant diseases, smoking status, the diagnosis of COPD and its clinical characteristics basic knowledge of the patient about COPD daily life of the patient, expectations from the therapy.

Participating in This Clinical Trial

Inclusion Criteria

  • Diagnosis of COPD – Outpatient treatment for any reason – Current or ex-smoker Exclusion Criteria:

  • An exacerbation of COPD that still lasts or that was experienced within last 3 months – History of asthma and/or allergic rhinitis – The presence of another important respiratory disease

Gender Eligibility: All

Minimum Age: 45 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • AstraZeneca
  • Provider of Information About this Clinical Study
    • Mujgan Ates / MC MD, AstraZeneca
  • Overall Official(s)
    • Zeynep Goztas, Study Director, AstraZeneca Turkey
    • Mehmet Polatli, Principal Investigator, Adnan Menderes University Faculty of Medicine

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.